FIELD: organic chemistry, pharmaceutical composition.
SUBSTANCE: new isoindoline-1-on-glucokinase activators of general formula I , as well as pharmaceutically acceptable salts or N-oxide thereof are disclosed. In formula A is phenyl optionally substituted with one or two halogen or one (law alkyl)sulfonyl group, or nitro group; R1 is C3-C9cycloalkyl; R2 is optionally monosubstituted five- or six-membered heterocyclic ring bonded via carbon atom in cycle to amino group, wherein five- or six-membered heteroaromatic ring contains one or two heteroatoms selected form sulfur, oxygen or nitrogen, one of which is nitrogen atom adjacent to carbon atom bonded to said amino group; said cycle is monocyclic or condensed with phenyl via two carbon atoms in cycle; said monosubstituted with halogen or law alkyl heteroaromatic ring has monosubstituted carbon atom in cycle which in not adjacent to carbon atom bonded to amino group; * is asymmetric carbon atom. Claimed compounds have glucokinase inhibitor activity and useful in pharmaceutical composition for treatment of type II diabetes.
EFFECT: new isoindoline-1-on-glucokinase activators useful in treatment of type II diabetes.
23 cl, 3 dwg, 43 ex
Title | Year | Author | Number |
---|---|---|---|
GLUCOKINASE ACTIVATING AGENTS | 2000 |
|
RU2242469C2 |
3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-c] PYRROLES AS GLUCOKINASE ACTIVATORS | 2011 |
|
RU2603191C2 |
2,3-DIHYDROISOINDOL-1-ONES POSSESSING INHIBITORY EFFECT ON MAO B ACTIVITY | 2003 |
|
RU2322437C2 |
NOVEL AZAINDOLE THIAZOLINONES AS ANTI-CANCER AGENTS | 2005 |
|
RU2391342C2 |
OXOAZETIDINE DERIVATIVES, METHOD FOR PRODUCING AND USING THEREOF IN MEDICINE AND COSMETIC MEDICINE | 2009 |
|
RU2671189C1 |
OXOAZETIDINE DERIVATIVES, METHOD FOR PRODUCING THEM AND USING THEM IN MEDICINE AND COSMETIC MEDICINE | 2009 |
|
RU2569886C2 |
PYRIMIDINE HYDRAZIDE COMPOUNDS AS PGDS INHIBITORS | 2008 |
|
RU2464262C2 |
NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS | 2000 |
|
RU2255937C2 |
AMINOMETHYL QUINOLONES USEFUL IFOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2629111C2 |
3-CYCLYL-2-(4-SULPHAMOYLPHENYL)-N-CYCLYLPROPIONAMIDE DERIVATIVES APPLICABLE FOR TREATING IMPAIRED GLUCOSE TOLERANCE AND DIABETES | 2006 |
|
RU2435757C2 |
Authors
Dates
2005-04-10—Published
2001-12-07—Filed